Schedule 13D ownership disclosure

EYEGATE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 30233M107

Event date: 2018-01-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
770,065
Percent of class
4.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-18-002447
Form type
SC 13D/A
Filer
KIORA PHARMACEUTICALS INC
CIK
CIK 1372514
Filed
Jan 17, 2018
Reporting period
Jan 12, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub